U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07369141) titled 'PREcision meDICine in Treatment in CardioVascular Disease' on Dec. 31, 2025.
Brief Summary: The main goal of PREDICT-CVS is to demonstrate that a personalized, AI-derived biomarker-guided medication treatment algorithm that provides advice to the treating professional is superior to prevent clinical events and improve quality of life (QoL) when compared to patients receiving standard treatment of care.
Participants will be randomized into two groups
* Group 1 - Standard treatment Participant will receive the usual treatment for heart failure, based on current medical guidelines.
* Group 2 - AI-supported treatment The professional...